MicroTransponder recently announced positive real-world outcomes for its Vivistim vagus nerve stimulation (VNS) system.
RenovoRx (Nasdaq:RNXT) announced that it priced an underwritten public offering of common stock worth proceeds of $12.1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback